AxisPharm provides integrated bioconjugate development services. We are experienced and equipped with a wide range of bioconjugation technologies to help you achieve timely delivery. Currently, we offer the following bioconjugation services:

  • Chemical synthesis of linkers and payloads
  • Development, optimization and manufacturing services for various bioconjugates, including ADC, AOC, etc.
  • Support for the preclinical lead generation using state-of-the-art, scalable conjugation technologies and analytical methods
  • Process development, optimization, and scale up
  • Bioconjugate analytical method development, validation, and technology transfer support
  • Formulation development (liquid and lyophilized) and drug product development